The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

KU ASCO 2019 Update on Recent Developments in AML - CX-01, HuF59 Anti-CD47 Antibody, Ivosidenib + Azacitidine

193 views
August 19, 2019
Comments 0
Login to view comments. Click here to Login